Jian Shi Technology-B (09877.HK): The research on LUX-VALVE PLUS TRINITY and the follow-up results of the JENSCLIP clinical study will be released at EUROPCR 2025, demonstrating good safety and efficacy performance.

Wisdom Finance APP News, Healthy Technology - B (09877.HK) announced that recently, the global multicenter clinical trial (TRINITY) 30-day clinical follow-up results of the LuX-ValvePlus transcatheter tricuspid valve replacement (TTVR) system and the one-year follow-up results of the JensClip transcatheter mitral valve repair (TMVr) system were officially released at EuroPCR 2025 in Paris, France.